摘要
目的:本研究旨在研究淀粉样蛋白(Aβ)诱导人视网膜色素上皮细胞系(ARPE-19)细胞产生血管生成因子的机制。 方法:本研究采用美国典型培养物保藏中心(ATCC)获得的ARPE-19细胞。 通过实时定量PCR(RT-PCR)测量血管内皮生长因子(VEGF),白细胞介素-8(IL-8),单核细胞趋化蛋白-1(MCP-1)和补体活化片段C3a和C5a的表达水平和酶联免疫吸附测定(ELISA)。运用流式细胞术测量线粒体相关活性氧(ROS)的产生。 结果:Aβ治疗ARPE-19细胞中VEGF,IL-8,MCP-1,C3a和C5a的表达显着增加。线粒体相关的ROS当暴露于Aβ时,其产生也显着增加。用二苯基碘化铵(DPI)抑制线粒体ROS显着降低了ARPE-19细胞对Aβ诱导的VEGF,IL-8,MCP-1,C3a和C5a的产生。抗AβC3a或抗-C5a中和抗体在用Aβ刺激时对ARPE-19细胞的VEGF,IL-8和MCP-1的分泌没有可检测的影响。 结论:我们的结果支持Aβ通过RPE细胞促进血管生成细胞因子VEGF,IL-8和MCP-1的产生参与脉络膜新血管形成(CNV)发病机制的假说。显示线粒体ROS在调节Aβ诱导的这些细胞因子的表达中起作用。
关键词: 淀粉样蛋白β,玻璃疣,脉络膜新血管形成,视网膜色素上皮,年龄相关性黄斑变性,线粒体相关活性氧。
Current Molecular Medicine
Title:The Role of Mitochondria-Associated Reactive Oxygen Species in the Amyloid β Induced Production of Angiogenic Factors b y ARPE-19 Cells
Volume: 17 Issue: 2
关键词: 淀粉样蛋白β,玻璃疣,脉络膜新血管形成,视网膜色素上皮,年龄相关性黄斑变性,线粒体相关活性氧。
摘要: Objective: This study aimed to investigate the mechanisms whereby Amyloidbeta (Aβ) induces the production of angiogenic factors by a human retinal pigment epithelial cell line (ARPE-19) cells.
Methods: ARPE-19 cells obtained from the American Type Culture Collection (ATCC) were utilized in this study. The expression level of vascular endothelial growth factor (VEGF), Interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1) and complement activation fragments C3a and C5a were measured by Real-time quantitative PCR (RT-PCR) and Enzyme-linked immunosorbent assay (ELISA). The production of mitochondria-associated reactive oxygen species (ROS) was measured by flow cytometry. Results: The expression of VEGF, IL-8, MCP-1, C3a and C5a was significantly increased in Aβ-treated ARPE-19 cells. Mitochondria-associated ROS production was also significantly increased when exposed to Aβ. Inhibition of mitochondrial ROS with Diphenyleneiodonium chloride (DPI) markedly decreased the Aβ induced production of VEGF, IL-8, MCP-1, C3a and C5a by ARPE-19 cells. Anti-C3a or anti-C5a neutralizing antibodies did not have a detectable influence on the secretion of VEGF, IL-8 and MCP-1 by ARPE-19 cells upon stimulation with Aβ. Conclusion: Our results support the hypothesis that Aβ is involved in the pathogenesis of choroidal neovascularization (CNV) formation by promoting the production of the angiogenic cytokines VEGF, IL-8 and MCP-1 by RPE cells. Mitochondrial ROS was shown to play a role in the regulation of Aβ induced expression of these cytokines.Export Options
About this article
Cite this article as:
The Role of Mitochondria-Associated Reactive Oxygen Species in the Amyloid β Induced Production of Angiogenic Factors b y ARPE-19 Cells, Current Molecular Medicine 2017; 17 (2) . https://dx.doi.org/10.2174/1566524017666170331162616
DOI https://dx.doi.org/10.2174/1566524017666170331162616 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Diversity of Epithelial Secreted Mucins
Current Organic Chemistry Expression and Function of Angiomodulating Cytokines in Rheumatoid Arthritis and Experimental Arthritis: Important Therapeutic Targets
Current Immunology Reviews (Discontinued) Cdc42 Signaling Pathway Inhibition as a Therapeutic Target in Ras- Related Cancers
Current Medicinal Chemistry Connecting A Tumor to the Environment
Current Pharmaceutical Design Gene Expression Analysis for High Throughput Screening Applications
Combinatorial Chemistry & High Throughput Screening Synthesis, Proton-Affinity and Anti-Cancer Properties of the Prodigiosin-Group Natural Products
Current Medicinal Chemistry - Anti-Cancer Agents Editorial [Hot Topic: ErbB Family and Downstream Signal Transduction Pathways as Targets for Anticancer Therapy (Guest Editor: F. Caponigro)]
Current Drug Targets The Case of Biotech-Derived Product Equivalence: Much Ado About Nothing?
Current Clinical Pharmacology Viral Hepatitis B: Established and Emerging Therapies
Current Medicinal Chemistry Environmentally Benign Synthetic Protocol for the Synthesis of Spiroquinazolinones Using Sustainable and Recyclable Choline Chloride Based Deep Eutectic Mixture
Current Organic Synthesis Inhibitors of AP-1 and NF-κB Mediated Transcriptional Activation: Therapeutic Potential in Autoimmune Diseases and Structural Diversity
Current Medicinal Chemistry Variability in Response to Cardiovascular Drugs
Current Clinical Pharmacology Graphene Oxide as Scaffolds for Stem Cells: An Overview
Current Molecular Medicine Complextation of Oppositely Charged Polymer: Novel Approaches for Drug Delivery
Current Drug Delivery Targeting Sphingosine-1-Phosphate Receptors in Cancer
Anti-Cancer Agents in Medicinal Chemistry High Density DNA Microarrays: Algorithms and Biomedical Applications
Current Medicinal Chemistry Ursolic Acid Attenuates HMGB1-induced LOX-1 Expression in Vascular Endothelial Cells in vitro and Inhibits Atherogenesis in Hypercholesterolemic Mice in vivo
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Elevated Homocysteine Levels in Parkinsons Disease: Is there Anything Besides L-Dopa Treatment?
Current Medicinal Chemistry Atrial Fibrillation During or After TAVI: Incidence, Implications and Therapeutical Considerations
Current Pharmaceutical Design Decreased Parathyroid Hormone Levels Despite Persistent Hypocalcemia in Patients with Kidney Failure Recovering from Septic Shock
Endocrine, Metabolic & Immune Disorders - Drug Targets